Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 6 | 0 | 0 | 0 | 0 |
| Cost of Goods | 6 | N/A | N/A | N/A | N/A |
| Operating Expenses | 19,358 | 1,211 | 1,340 | 976 | 26 |
| Operating Income | -19,351 | -1,211 | -1,340 | -976 | -26 |
| Interest Expense | 8,531 | 98 | 9 | 0 | 0 |
| Other Income | 3,402 | 0 | 5,813 | 4,317 | 0 |
| Pre-tax Income | -24,481 | -1,309 | 4,464 | 3,340 | -26 |
| Income Tax | N/A | -1 | N/A | N/A | N/A |
| Net Income Continuous | -24,481 | -1,308 | 4,464 | 3,340 | -26 |
| Net Income | $-24,481 | $-1,310 | $4,464 | $3,340 | $-26 |
| EPS Basic Total Ops | -16.38 | -1.90 | 9.20 | 4.40 | 0.00 |
| EPS Basic Continuous Ops | -16.38 | -1.90 | 65.71 | 18.59 | -0.16 |
| EPS Diluted Total Ops | -16.38 | -1.90 | 9.20 | 4.40 | 0.00 |
| EPS Diluted Continuous Ops | -16.38 | -1.90 | 65.71 | 18.59 | -0.16 |
| EBITDA(a) | $-11,332 | $-1,211 | $-1,340 | $-976 | $-26 |